Proposed Collection; 60-Day Comment Request; Application Forms for the NIDA Summer Research Internship Program (NIDA), 53164-53165 [2015-21702]
Download as PDF
53164
Federal Register / Vol. 80, No. 170 / Wednesday, September 2, 2015 / Notices
Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated co-exclusive license
should be directed to: Uri Reichman,
Ph.D., MBA, Licensing and Patenting
Manager, Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804. Telephone:
(301) 435–4616; Facsimile: (301) 402–
0220; Email: reichmau@mail.nih.gov.
ADDRESSES:
This
technology is directed to gene
biomarkers for the diagnosis and
potential treatment of acute ischemic
stroke. Stroke is the third leading cause
of death in the United States, of which
87% are ischemic stroke and result in
death within 30 days in 8–12% of the
cases. Currently, recombinant tissue
plasminogen activator (rtPA, trade name
alteplase), is the only FDA approved
ischemic stroke treatment, and it is only
effective when administered to patients
within three hours from the onset of
symptoms. Unfortunately, the median
time from stroke symptom onset to
presentation to the emergency
department is 3–6 hours. Although
advances in neuroimaging and clinical
management have helped with patient
survival rates, these techniques are not
infallible and at times result in
misdiagnosis. The biomarkers identified
in this technology may be used to
develop a diagnostic testing device for
determining stroke subtype in the field.
The prospective co-exclusive license
will be royalty bearing and will comply
with the terms and conditions of 35
U.S.C. 209 and 37 CFR part 404. The
prospective co-exclusive license may be
granted unless within thirty (30) days
from the date of this published notice,
the NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated co-exclusive
license. Comments and objections
submitted to this notice will not be
made available for public inspection
and, to the extent permitted by law, will
not be released under the Freedom of
Information Act, 5 U.S.C. 552.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: August 28, 2015.
Richard U. Rodriguez,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. 2015–21718 Filed 9–1–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:04 Sep 01, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Microbiology and Infectious
Diseases Biological Resource Repository
(MID–BRR).
Date: September 25, 2015.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health; Room
2C100; 5601 Fishers Lane; Rockville, MD
20892; (Telephone Conference Call).
Contact Person: Annie Walker-Abbey;
Scientific Review Officer; Scientific Review
Program; NIAID/NIH/DHHS; 5601 Fishers
Lane, Room 3E70A; Rockville, MD 20852;
240–627–3390; aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 27, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–21703 Filed 9–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Application Forms for the
NIDA Summer Research Internship
Program (NIDA)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
National Institute of Drug Abuse, the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Albert Avila, Ph.D.,
Director, Office of Diversity and Health
Disparities, NIDA, NIH, 6001 Executive
Blvd., Room 3106, Rockville, MD 20852,
or call non-toll-free number (301) 443–
0441 or Email your request, including
your address to: aavila@nida.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: NIDA Summer
Research Internship Program, 0925–
NEW, National Institute on Drug Abuse,
NIDA, National Institutes of Health
(NIH).
Need and Use of Information
Collection: The NIDA Summer Research
Internship program introduces high
school and undergraduate students of
underrepresented populations to
substance abuse research through
internships with NIDA grantees at
universities across the United States and
Puerto Rico. Students intern with NIDA
principal investigators for 8–10 weeks
during the summer. The internship
experience may include laboratory
experiments, formal courses, data
collection, data analysis, patient
recruitment, manuscript preparation,
literature reviews and library research.
E:\FR\FM\02SEN1.SGM
02SEN1
53165
Federal Register / Vol. 80, No. 170 / Wednesday, September 2, 2015 / Notices
This outreach and pipeline program
exposes students interested in
biomedical and behavioral research
careers to cutting edge substance abuse
research.
This program fills a significant unmet
need to encourage and support
individuals from underrepresented
mentorship and training opportunities
with premier substance abuse research
laboratories around the country.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
350.
groups to pursue careers in substance
abuse research. The NIDA Summer
Research Internship program offers a
unique opportunity to increase the
diversity and creativity of the
biomedical research workforce by
fostering the development of young
talent through the creation of
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Type of respondent
Student Application Form .................
Student Application Form .................
Individuals/Households—High
School Students.
Individuals/Households—Undergraduates.
Dated: August 27, 2015.
Genevieve deAlmeida,
Project Clearance Liaison, NIDA, NIH.
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2015–0001]
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Final notice.
AGENCY:
New or modified Base (1percent annual chance) Flood
Elevations (BFEs), base flood depths,
Special Flood Hazard Area (SFHA)
boundaries or zone designations, and/or
regulatory floodways (hereinafter
referred to as flood hazard
determinations) as shown on the
indicated Letter of Map Revision
(LOMR) for each of the communities
listed in the table below are finalized.
Each LOMR revises the Flood Insurance
Rate Maps (FIRMs), and in some cases
the Flood Insurance Study (FIS) reports,
currently in effect for the listed
communities. The flood hazard
determinations modified by each LOMR
will be used to calculate flood insurance
premium rates for new buildings and
their contents.
DATES: The effective date for each
LOMR is indicated in the table below.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
19:04 Sep 01, 2015
Jkt 235001
Frm 00065
Fmt 4703
Average time
per response
( in hours)
Total annual
burden hour
1
1
100
250
1
1
250
Each LOMR is available for
inspection at both the respective
Community Map Repository address
listed in the table below and online
through the FEMA Map Service Center
at www.msc.fema.gov.
FOR FURTHER INFORMATION CONTACT: Luis
Rodriguez, Chief, Engineering
Management Branch, Federal Insurance
and Mitigation Administration, FEMA,
500 C Street SW., Washington, DC
20472, (202) 646–4064, or (email)
Luis.Rodriguez3@fema.dhs.gov; or visit
the FEMA Map Information eXchange
(FMIX) online at www.floodmaps.fema.
gov/fhm/fmx_main.html.
SUPPLEMENTARY INFORMATION: The
Federal Emergency Management Agency
(FEMA) makes the final flood hazard
determinations as shown in the LOMRs
for each community listed in the table
below. Notice of these modified flood
hazard determinations has been
published in newspapers of local
circulation and 90 days have elapsed
since that publication. The Deputy
Associate Administrator for Mitigation
has resolved any appeals resulting from
this notification.
The modified flood hazard
determinations are made pursuant to
section 206 of the Flood Disaster
Protection Act of 1973, 42 U.S.C. 4105,
and are in accordance with the National
Flood Insurance Act of 1968, 42 U.S.C.
4001 et seq., and with 44 CFR part 65.
For rating purposes, the currently
effective community number is shown
and must be used for all new policies
and renewals.
The new or modified flood hazard
information is the basis for the
floodplain management measures that
PO 00000
Number of
responses per
respondent
100
ADDRESSES:
[FR Doc. 2015–21702 Filed 9–1–15; 8:45 am]
VerDate Sep<11>2014
Number of
respondents
Sfmt 4703
the community is required either to
adopt or to show evidence of being
already in effect in order to remain
qualified for participation in the
National Flood Insurance Program
(NFIP).
This new or modified flood hazard
information, together with the
floodplain management criteria required
by 44 CFR 60.3, are the minimum that
are required. They should not be
construed to mean that the community
must change any existing ordinances
that are more stringent in their
floodplain management requirements.
The community may at any time enact
stricter requirements of its own or
pursuant to policies established by other
Federal, State, or regional entities.
This new or modified flood hazard
determinations are used to meet the
floodplain management requirements of
the NFIP and also are used to calculate
the appropriate flood insurance
premium rates for new buildings, and
for the contents in those buildings. The
changes in flood hazard determinations
are in accordance with 44 CFR 65.4.
Interested lessees and owners of real
property are encouraged to review the
final flood hazard information available
at the address cited below for each
community or online through the FEMA
Map Service Center at
www.msc.fema.gov.
(Catalog of Federal Domestic Assistance No.
97.022, ‘‘Flood Insurance.’’)
Dated: August 10, 2015.
Roy E. Wright,
Deputy Associate Administrator for Insurance
and Mitigation, Department of Homeland
Security, Federal Emergency Management
Agency.
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 80, Number 170 (Wednesday, September 2, 2015)]
[Notices]
[Pages 53164-53165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21702]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Application Forms
for the NIDA Summer Research Internship Program (NIDA)
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Institute of Drug
Abuse, the National Institutes of Health (NIH) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited to address one or more of the following points:
(1) Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) The quality, utility, and clarity of the information to be
collected; and (4) Minimize the burden of the collection of information
on those who are to respond, including the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Albert
Avila, Ph.D., Director, Office of Diversity and Health Disparities,
NIDA, NIH, 6001 Executive Blvd., Room 3106, Rockville, MD 20852, or
call non-toll-free number (301) 443-0441 or Email your request,
including your address to: aavila@nida.nih.gov. Formal requests for
additional plans and instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: NIDA Summer Research Internship Program, 0925-
NEW, National Institute on Drug Abuse, NIDA, National Institutes of
Health (NIH).
Need and Use of Information Collection: The NIDA Summer Research
Internship program introduces high school and undergraduate students of
underrepresented populations to substance abuse research through
internships with NIDA grantees at universities across the United States
and Puerto Rico. Students intern with NIDA principal investigators for
8-10 weeks during the summer. The internship experience may include
laboratory experiments, formal courses, data collection, data analysis,
patient recruitment, manuscript preparation, literature reviews and
library research.
[[Page 53165]]
This outreach and pipeline program exposes students interested in
biomedical and behavioral research careers to cutting edge substance
abuse research.
This program fills a significant unmet need to encourage and
support individuals from underrepresented groups to pursue careers in
substance abuse research. The NIDA Summer Research Internship program
offers a unique opportunity to increase the diversity and creativity of
the biomedical research workforce by fostering the development of young
talent through the creation of mentorship and training opportunities
with premier substance abuse research laboratories around the country.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 350.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response ( Total annual
respondent respondents respondent in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Student Application Form...... Individuals/ 100 1 1 100
Households--Hig
h School
Students.
Student Application Form...... Individuals/ 250 1 1 250
Households--Und
ergraduates.
----------------------------------------------------------------------------------------------------------------
Dated: August 27, 2015.
Genevieve deAlmeida,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015-21702 Filed 9-1-15; 8:45 am]
BILLING CODE 4140-01-P